Featuring content from daily briefings generated October 9, 2026 through October 12, 2026.

Open the web version of this rollup

📰 News Media (Click for more)

• ⚠️ [Baton Rouge, LA] 'One pill will kill:' Baton Rouge family warns of fentanyl dangers - wbrz.com
• ⚠️ [Oxford, MS] Cause of death for Ole Miss students found dead with illegal kratom pills revealed in court - nypost.com
• ⚖️ [National] Kratom industry engaged in multimillion lobbying effort to ban synthetic product while pushing natural version - nypost.com
• 🏛️ [Colorado] Phil Weiser says fights as attorney general — including Meta, opioid settlements — set foundation for governorship - denverpost.com
• 💊 [National] Why Ketamine Immobilizes Some Users - nytimes.com

🗣️ Social Pulse (Click for more)

Lived/Living Experience

• 💬 I've only been physically dependent on opioids. I'm going to be really honest. When my palliative doctor retired, I ended up having to take fentanyl from the street for 2 yrs. I almost died 3 X's from tranq that was... - @earthgodess48 on X

Innovation

• 🧪 Federal chemists just published 2 1/2 years of testing on the illegal drug supply: 4,563 samples, collected January 2024 through June 2026. The story isn't fentanyl. It's the rest of the bag: in early 2024 a sample... - @EdwarddMaier on X
• 🧪 NIST analyzed 4,563 drug residue samples collected across the United States from January 2024 to June 2026. The mix of fentanyl adulterants changed by region and over time, while rapid mass spectrometry identified... - @DecodingThing on X

Opposition Views

• 🚫 Tom it's never been about supporting drug users. "Harm reduction" is a euphemism for let's use their life and death situation as addicts to steal funds intended for them and get rich off keeping their misery... - @michaeldineen58 on X

🏙 City Updates

• 📧 - [Philadelphia, PA] - October 9, 2026 - PDPH Update: New ICD-10-CM codes for documenting medetomidine toxicity available - newsletter - view newsletter online for more info

📚 Academic Research (Click for more)

• 🚑 Prehospital Buprenorphine: A National Cross-Sectional Analysis - Western Journal of Emergency Medicine - 2026-10-11 - doi.org
• 🧪 Rapid chemical profiling of ecstasy tablets using portable near-infrared spectroscopy for forensic intelligence and early response applications - Forensic Science International - 2026-10-08 - doi.org
• 🧪 Trust, place, and polysubstance use shape the feasibility of community-based drug checking in the Southern United States: A mixed-methods implementation study - 2026-10-11 - doi.org

⚖️ Law & Policy

Federal Agencies

• 🧪 [United States] [Final Rule] Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction - federalregister.gov

City Ordinances

• 🌿 [New York, NY] ...relation to refusing to renew, suspending, or revoking a license of a tobacco retail dealer or an electronic cigarette retail dealer that has violated... - legistar.council.nyc.gov

💸 Funding (Click to expand)

Current

• 🛠️ Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA) - Deadline: Nov 2, 2026
• NEW · 🧒 Office of Juvenile Justice Delinquency Prevention - OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use - Deadline: Nov 16, 2026
• NEW · 🧒 Office of Juvenile Justice Delinquency Prevention - OJJDP FY 2026 Opioid Affected Youth Initiative - Deadline: Nov 16, 2026
• 🔬 National Institutes of Health - HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) - Deadline: Jan 26, 2027

📣 Activism (Click for more)

• 📣 Treatment Advocacy Center - Urge Your U.S. Representative to Support the IMD Care Act
• 📣 Treatment Advocacy Center - Urge Your U.S. Representative to Support the IMD Care Act, H.R. 10647

Submit a Link

Click here to submit community content to the Harm Reduction Briefing

Newsletter Improvements

I love feedback and requests – [email protected]

Links

• Website
• Search Engine
• Contact